Anti-IgA Antibody by ELISA
Also known as: ANTI IGA
Use
This test is used prior to transfusion or in the case of possible transfusion reactions to determine the presence of anti-IgA antibodies in patients with selective IgA deficiency. Patients with IgG antibodies against IgA may suffer from anaphylactoid reactions when given intravenous immunoglobulin (IVIG) that contains small quantities of IgA.
Special Instructions
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered. Storage/transport temperature for specimens is frozen, though room temperature or refrigerated conditions are acceptable.
Limitations
The performance characteristics of this test were determined by Eurofins Viracor. It has not been cleared or approved by the U.S. Food and Drug Administration. This may impact the test's applicability in certain regulatory environments.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 13312-4
Result Turnaround Time
5-11 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
ARUP standard transport tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 1 week |
| Frozen | 2 weeks |